Trilaciclib

(Synonyms: G1T28)
1 Cited Publications
Revisión del cliente

Based on 1 publication(s) in Google Scholar

Trilaciclib (G1T28) is an orally active CDK4/6 inhibitor with IC50 values of 1 nM and 4 nM for CDK4 and CDK6, respectively. . Trilaciclib can effectively inhibit tumor cell proliferation and reduce the hematological toxicity caused by chemotherapy. Trilaciclib attenuates apoptosis and myelosuppression induced by 5FU (HY-90006) chemotherapy.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.42%
  • No. CAS: 1374743-00-6
  • Fòrmula: C24H30N8O
  • Peso molecular:446.55
  • Almacenamiento:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Trilaciclib

More

Ver todos los productos específicos de isoformas CDK

More
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00